Trial Data Collection—Paper vs. Electronic

The use of electronic data collection tools is prevalent across clinical trial phases. Respondents with visibility into Phase IV studies report 90% of these studies use electronic data capture tools, either exclusively or as part of a hybrid EDC/paper strategy.

 

Data from this edition of our Industry Statistics can be found in our report EDC Market Dynamics and Service Provider Performance (3rd Edition).

 

Originally published in Life Science Leader.

View Resource